Accu-chek and coaguchek
Ended Awarded Last action
- Contract number
- 36C25023F0072
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $26,699
Award facts
- Contract value 34% obligated
- $77,498.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$81 | |
| Funding Only Action | $4,132 | |
| Funding Only Action | -$4,759 | |
| Funding Only Action | -$3,544 | |
| Exercise an Option | $3,484 | |
| Exercise an Option | $13,733 | |
| Original award | $13,733 |
About this award
Roche Diagnostics Corporation was awarded a $77,498 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 10 for ACCU-CHEK and CoaguCHEK diagnostic products. This contract, which became effective on October 1, 2022, represents a decrease of $81.20 from a prior award and will be completed by September 30, 2027. The delivery order was issued under the parent In Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule contract, which provides federal agencies with pre-negotiated pricing for diagnostic technologies. No set-aside designation was utilized for this award, indicating open competition in the federal marketplace.
The work will be performed in Castleton, Indiana. ACCU-CHEK and CoaguCHEK are point-of-care testing devices widely used in healthcare settings for blood glucose monitoring and coagulation testing, respectively. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic solutions, holds multiple significant contracts across the VA and other federal healthcare agencies for laboratory equipment, reagents, and testing systems. This delivery order enables Veterans Integrated Service Network 10 to access these essential diagnostic technologies through established contract terms under the GSA Schedule vehicle.
Quick answers
Who was awarded contract 36C25023F0072?
36C25023F0072 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C25023F0072 worth?
The government has obligated $26,699 on 36C25023F0072. Its current value, with exercised options, is $77,498.
Is contract 36C25023F0072 an order under another contract?
Yes. 36C25023F0072 is a delivery order under 36F79722D0128, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25023F0072 competed?
The extent of competition for 36C25023F0072 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award